|
gptkbp:instanceOf
|
gptkb:anabolic_steroid
|
|
gptkbp:activeIngredient
|
gptkb:nandrolone_decanoate
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:approvedForMedicalUse
|
1962
|
|
gptkbp:ATCCode
|
A14AB01
|
|
gptkbp:bannedIn
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:brand
|
gptkb:Deca-Durabolin
|
|
gptkbp:chemicalFormula
|
C28H44O3
|
|
gptkbp:class
|
gptkb:controlled_substance
|
|
gptkbp:developedBy
|
gptkb:Organon
|
|
gptkbp:discoveredIn
|
1960
|
|
gptkbp:eliminationHalfLife
|
6-12 days
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:genericName
|
gptkb:nandrolone_decanoate
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:ND
gptkb:Deca
gptkb:Deca-Durabolin
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
428.65 g/mol
|
|
gptkbp:notableFor
|
long-acting ester
|
|
gptkbp:pregnancyCategory
|
X (contraindicated)
|
|
gptkbp:relatedTo
|
gptkb:nandrolone_phenylpropionate
testosterone
|
|
gptkbp:routeOfAdministration
|
intramuscular
|
|
gptkbp:sideEffect
|
hair loss
acne
liver toxicity
gynecomastia
suppression of natural testosterone
|
|
gptkbp:usedFor
|
treatment of anemia
muscle wasting diseases
|
|
gptkbp:usedIllegallyFor
|
performance enhancement
muscle growth
|
|
gptkbp:bfsParent
|
gptkb:nandrolone
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Deca-Durabolin
|